Revista de bioequivalencia y biodisponibilidad

Experimental Drug Trial

An experimental drug is a medicinal product (a drug or vaccine) that has not yet received an acceptance from governmental regulatory authorities for their routine use in human or veterinary medicine. A medicinal product may be accepted for use in one disease or condition but still be considered experimental for other diseases or conditions.
In the United States, the body responsible for approval is the U.S. Food and Drug Administration (FDA), which must grant the substance Investigational New Drug (IND) status before it can be tested in human clinical trials or animal clinical trials. IND status requires the drug's sponsor to submit an IND application that includes data from laboratory and animal testing for safety and efficacy.

Related Journals of Experimental Drug Trial
Journal of Bioanalysis & Biomedicine, Journal of Biomedical and Pharmaceutical Research, Chemical Speciation & Bioavailability, Journal of Bioequivalence & Bioavailability, MOJ Bioequivalence & Bioavailability, International Journal of BioAnalytical Methods & BioEquivalence Studies, Bioanalytical Methods & Bioequivalence Studies, International Research Journal for Inventions in Pharmaceutical Sciences, Enliven: Biosimilars and Bioavailablity, Pharmaceutical Regulatory Affairs: Open Access, Journal of Molecular Pharmaceutics & Organic Process Research.